List of SBIR/STTR awards granted to Zymeron Corporation

where

SBIR/STTR Award Recipient

Zymeron Corporation

Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
‌ Zymeron Corporation SBIR Phase II Award, August 2022	A SBIR Phase II contract was awarded to Zymeron Corporation in August, 2022 for $1,491,568.0 USD from the U.S. Department of Defense and DARPA.	Zymeron Corporation	U.S. Department of Defense	DARPA	SBIR	HR001122C0128	Phase II	1,491,568	August 26, 2022	sbir.gov/node/2321565
‌ Zymeron Corporation SBIR Phase II Award, July 2022	A SBIR Phase II contract was awarded to Zymeron Corporation in July, 2022 for $1,100,000.0 USD from the U.S. Department of Defense and Defense Health Agency.	Zymeron Corporation	U.S. Department of Defense	Defense Health Agency	SBIR	W81XWH22C0073	Phase II	1,100,000	July 6, 2022	sbir.gov/node/2327449
‌ Zymeron Corporation SBIR Phase I Award, May 2021	A SBIR Phase I contract was awarded to Zymeron Corporation in May, 2021 for $224,999.0 USD from the U.S. Department of Defense and DARPA.	Zymeron Corporation	U.S. Department of Defense	DARPA	SBIR	HR001121C0153	Phase I	224,999	May 10, 2021	sbir.gov/node/2163757
‌ Zymeron Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zymeron Corporation for $299,998.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Zymeron Corporation		National Institutes of Health	SBIR	75N93020C00036	Phase I	299,998		sbir.gov/node/1944661
‌ Zymeron Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zymeron Corporation for $299,920.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Zymeron Corporation		National Institutes of Health	SBIR	75N93019C00021	Phase I	299,920		sbir.gov/node/1675275
‌ Zymeron Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zymeron Corporation for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Zymeron Corporation		National Institutes of Health	SBIR	75N93020C00047	Phase I	300,000		sbir.gov/node/1944625
‌ Zymeron Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zymeron Corporation for $299,998.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Zymeron Corporation		National Institutes of Health	SBIR	75N91019C00015	Phase I	299,998		sbir.gov/node/1675761
‌ Zymeron Corporation SBIR Phase I Award, October 2019	A SBIR Phase I contract was awarded to Zymeron Corporation in October, 2019 for $111,494.0 USD from the U.S. Department of Defense and United States Army.	Zymeron Corporation	U.S. Department of Defense	United States Army	SBIR	W81XWH-20-P-0035	Phase I	111,494	October 30, 2019	sbir.gov/node/1929385
‌ Zymeron Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zymeron Corporation for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Zymeron Corporation		National Institutes of Health	SBIR	75N93020C00011	Phase I	300,000		sbir.gov/node/1944769
‌ Zymeron Corporation SBIR Phase I Award, September 2020	A SBIR Phase I contract was awarded to Zymeron Corporation in September, 2020 for $249,992.0 USD from the U.S. Department of Defense and Defense Health Agency.	Zymeron Corporation	U.S. Department of Defense	Defense Health Agency	SBIR	W81XWH20P0130	Phase I	249,992	September 24, 2020	sbir.gov/node/1918981
‌ Zymeron Corporation STTR Phase I Award, January 2019	A STTR Phase I contract was awarded to Zymeron Corporation in January, 2019 for $149,928.0 USD from the U.S. Department of Defense and United States Army.	Zymeron Corporation	U.S. Department of Defense	United States Army	STTR	W81XWH-19-C-0037	Phase I	149,928	January 23, 2019	sbir.gov/node/1951821
‌ Zymeron Corporation SBIR Phase I Award, July 2021	A SBIR Phase I contract was awarded to Zymeron Corporation in July, 2021 for $249,999.0 USD from the U.S. Department of Defense and Defense Health Agency.	Zymeron Corporation	U.S. Department of Defense	Defense Health Agency	SBIR	W81XWH21P0106	Phase I	249,999	July 26, 2021	sbir.gov/node/2173753
‌ Zymeron Corporation SBIR Phase II Award,	A SBIR Phase II contract was awarded to Zymeron Corporation for $1,500,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Zymeron Corporation		National Institutes of Health	SBIR	75N93019C00031	Phase II	1,500,000		sbir.gov/node/1675407
‌ Zymeron Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zymeron Corporation for $599,061.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Zymeron Corporation		National Institutes of Health	SBIR	272201800015C-0-0-0	Phase I	599,061		sbir.gov/node/1582395
‌ Zymeron Corporation SBIR Phase I Award, October 2018	A SBIR Phase I contract was awarded to Zymeron Corporation in October, 2018 for $149,967.27 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense.	Zymeron Corporation	U.S. Department of Defense	Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense	SBIR	W911QY-19-C-0010	Phase I	149,967.27	October 15, 2018	sbir.gov/node/1842011
‌ Zymeron Corporation SBIR Phase I Award, March 2022	A SBIR Phase I contract was awarded to Zymeron Corporation in March, 2022 for $167,495.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense.	Zymeron Corporation	U.S. Department of Defense	Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense	SBIR	W911SR-22-P-0012	Phase I	167,495	March 16, 2022	sbir.gov/node/2237893
‌ Zymeron Corporation SBIR Phase I Award, January 2020	A SBIR Phase I contract was awarded to Zymeron Corporation in January, 2020 for $167,494.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense.	Zymeron Corporation	U.S. Department of Defense	Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense	SBIR	W911NF-20-P-0019	Phase I	167,494	January 28, 2020	sbir.gov/node/1919977
‌ Zymeron Corporation SBIR Phase II Award, February 2022	A SBIR Phase II contract was awarded to Zymeron Corporation in February, 2022 for $2,999,993.0 USD from the U.S. Department of Defense and Defense Health Agency.	Zymeron Corporation	U.S. Department of Defense	Defense Health Agency	SBIR	W81XWH22C0012	Phase II	2,999,993	February 7, 2022	sbir.gov/node/2348367
‌ Zymeron Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zymeron Corporation for $299,810.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Zymeron Corporation		National Institutes of Health	SBIR	75N91018C00035-0-0-0	Phase I	299,810		sbir.gov/node/1563397
‌ Zymeron Corporation SBIR Phase II Award, September 2018	A SBIR Phase II contract was awarded to Zymeron Corporation in September, 2018 for $983,423.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense.	Zymeron Corporation	U.S. Department of Defense	Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense	SBIR	HDTRA1-18-C-0043	Phase II	983,423	September 28, 2018	sbir.gov/node/1613211
‌ Zymeron Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zymeron Corporation for $400,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Zymeron Corporation		National Institutes of Health	SBIR	75N91022C00029	Phase I	400,000		sbir.gov/node/2313283
‌ Zymeron Corporation SBIR Phase I Award, May 2019	A SBIR Phase I contract was awarded to Zymeron Corporation in May, 2019 for $107,995.15 USD from the U.S. Department of Defense and United States Army.	Zymeron Corporation	U.S. Department of Defense	United States Army	SBIR	W56HZV-19-C-0104	Phase I	107,995.15	May 28, 2019	sbir.gov/node/1867549
‌ Zymeron Corporation STTR Phase II Award, February 2021	A STTR Phase II contract was awarded to Zymeron Corporation in February, 2021 for $1,099,999.0 USD from the U.S. Department of Defense and United States Army.	Zymeron Corporation	U.S. Department of Defense	United States Army	STTR	W81XWH-21-C-0008	Phase II	1,099,999	February 22, 2021	sbir.gov/node/2162459
‌ Zymeron Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zymeron Corporation for $299,794.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Zymeron Corporation		National Institutes of Health	SBIR	75N93019C00006	Phase I	299,794		sbir.gov/node/1675317
‌ Zymeron Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zymeron Corporation for $156,500.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention.	Zymeron Corporation		Centers for Disease Control and Prevention	SBIR	75D30120P09252	Phase I	156,500		sbir.gov/node/1944247

Results per page:

38 results

0 selected

38 results

0 selected